XML 77 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue (Tables)
 9 Months Ended
Sep. 30, 2019
Revenue [Abstract]  
Disaggregation of Revenue [Table Text Block]

The following table presents the approximate percentage of our net sales by market group:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Biologics
26
%
 
21
%
 
25
%
 
21
%
Generics
20
%
 
21
%
 
20
%
 
21
%
Pharma
30
%
 
34
%
 
31
%
 
35
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by product category:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
High-Value Components
42
%
 
41
%
 
43
%
 
42
%
Standard Packaging
28
%
 
31
%
 
29
%
 
32
%
Delivery Devices
6
%
 
4
%
 
4
%
 
3
%
Contract-Manufactured Products
24
%
 
24
%
 
24
%
 
23
%
 
100
%
 
100
%
 
100
%
 
100
%
The following table presents the approximate percentage of our net sales by geographic location:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Americas
48
%
 
51
%
 
48
%
 
48
%
Europe, Middle East, Africa
44
%
 
41
%
 
44
%
 
44
%
Asia Pacific
8
%
 
8
%
 
8
%
 
8
%
 
100
%
 
100
%
 
100
%
 
100
%
Change in Contract with Customer, Asset and Liability [Abstract]
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:
 
($ in millions)
Contract assets, December 31, 2018
$
9.1

Contract assets, September 30, 2019
9.4

Change in contract assets - increase (decrease)
$
0.3

 
 
Deferred income, December 31, 2018
$
(33.4
)
Deferred income, September 30, 2019
(30.9
)
Change in deferred income - decrease (increase)
$
2.5